glp-1 drugs kidney disease Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Glucagon-like Peptide Receptor Agonists and
Description
The prescription will be sent to your chosen pharmacy with a specific instruction: Send to Medicare GLP-1 Bridge for Weight Management. This wording is critical
The study population is predominantly older, white and male, reflecting the VA patient population, though results were consistent in a separate analysis of more than 35,000 women
And weeks 36 through 48 approached a plateau in most participants, with weight either stabilizing or declining very slowly
It works by decreasing appetite and cravings
